CLINUVEL PHARMACEUTICALS LTD

12.280

+0.0500.41%

Volume:262.55K

Turnover:3.22M

Market Cap:613.35M

PE:15.96

High:12.590

Open:12.500

Low:12.030

Close:12.230

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+0.56%

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":12.28,"timestamp":1741065120000,"preClose":12.23,"halted":0,"volume":262551,"delay":0,"changeRate":0.004088,"change":0.05,"floatShares":41256001,"shares":49946800,"eps":0.769445,"lyrEps":0.7151,"pbRate":2.82,"amount":3220374,"amplitude":0.045789,"volumeRatio":0.4655374185237014,"dividePrice":0.05,"prevYearClose":12.06,"fiveDayClose":10.97,"twentyDayClose":11.55},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41256001,"roa":"14.48%","roe":"19.59%","lyrEps":0.7151,"volumeRatio":0.4655374185237014,"shares":49946800,"dividePrice":0.05,"high":12.59,"amplitude":0.045789,"preClose":12.23,"low":12.03,"week52Low":10.89,"pbRate":"2.82","psRate":"6.67","week52High":17.652,"institutionHeld":0,"latestPrice":12.28,"eps":0.769445,"divideRate":0.004072,"volume":262551,"delay":0,"ttmEps":0.769445,"open":12.5,"prevYearClose":12.06,"prevWeekClose":11.49,"prevMonthClose":11.49,"prevQuarterClose":12.06,"fiveDayClose":10.97,"twentyDayClose":11.55,"sixtyDayClose":12.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"},{"date":"2024-08-29","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724889600000,"name":null,"time":"","dateTimestamp":1724853600000,"actualEps":null},{"date":"2024-02-22","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":"2023-08-29","type":"dividend","market":"AU","newRecordDate":"2023-09-06","defaultRemindTime":1693872000000,"name":"Clinuvel Pharmaceuticals Ltd","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693836000000,"payDate":"2023-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CUV.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.005629}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUV.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516660815","title":"Imugene Appoints CFO; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516660815","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516660815?lang=en_us&edition=fundamental","pubTime":"2025-03-04 07:35","pubTimestamp":1741044931,"startTime":"0","endTime":"0","summary":"Imugene  appointed Clinuvel Pharmaceuticals'  former Chief Financial Officer Darren Keamy as CFO, effective immediately, according to a Tuesday filing with the Australian bourse.Keamy will succeed current CFO Mike Tonroe, the filing said.Shares of the pharmaceutical company fell 3% in recent trade,Price : $0.04, Change: $-0.00100, Percent Change: -2.78%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","CUV.AU","BK7067","IMU.AU","XKO.AU","BK7508","XAO.AU"],"gpt_icon":0},{"id":"2514890322","title":"Clinuvel Pharmaceuticals Posts Higher Fiscal H1 Earnings, Revenue; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514890322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514890322?lang=en_us&edition=fundamental","pubTime":"2025-02-27 08:29","pubTimestamp":1740616182,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  reported Thursday that its earnings per diluted share in the fiscal first half rose to AU$0.28 from AU$0.212 a year earlier.Analysts polled by Visible Alpha were expecting an EPS of AU$0.20.Revenue for the six months ended Dec. 31, 2024, was AU$35.6 million, up from AU$32.3 million in the same period a year earlier. Analysts surveyed by Visible Alpha expected AU$35.6 million.The company's shares rose past 8% in recent Thursday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUV.AU"],"gpt_icon":0},{"id":"2514894068","title":"Clinuvel Pharmaceuticals Ltd H1 Net Income AUD 14.08 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514894068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514894068?lang=en_us&edition=fundamental","pubTime":"2025-02-27 07:43","pubTimestamp":1740613383,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLXDE4177:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CUV.AU","BK7508"],"gpt_icon":0},{"id":"2514074535","title":"ASX Growth Companies With High Insider Ownership For February 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514074535","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514074535?lang=en_us&edition=fundamental","pubTime":"2025-02-26 12:02","pubTimestamp":1740542556,"startTime":"0","endTime":"0","summary":"As the ASX 200 experiences a slight dip, influenced by persistent underlying inflation and cautious market sentiment, investors are closely monitoring sectors like Energy and Industrials which have shown resilience. In this fluctuating environment, growth companies with high insider ownership can offer unique insights into potential stability and alignment of interests between management and shareholders.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 101 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Operations: The company's revenue primarily comes from its mine operations, generating A$366.04 million.Operations: The company's revenue segment consists of A$413.26 million generated from its quick service restaurant operations across multiple international markets.Guzman y Gomez demonstrates promising growth with substantial insider ownership, evidenced by its recent inclusion in the S&P Global BMI In","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-high-insider-040236338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7116","GYG.AU","BK7137","BK7096","MM8.AU","ACR.AU","GTI.AU","BK7043","XKO.AU","AAL.AU","BK7158","BK7504","BK7508","BK7084","XAO.AU","3DP.AU","XJO.AU","BK7507","FND.AU","BK7093","BK7077","BK7067","BK7095","AVA.AU","MIN.AU","NWF.AU","EMR.AU","BK7016","PLT.AU","BK7104","CUV.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":66}]}}